ClinicalTrials.gg
RecruitingNCT07686809Updated Jul 7, 2026

Effect of Lower Extremity Modified Constraint-induced Movement Therapy on Locomotion in Children With Hemiplegia

An interventional study of Modified constraint-induced movement therapy and Conventional physical therapy in Spastic Hemiplegic Cerebral Palsy, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 6 Years to 8 Years. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
6 Years to 8 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Cerebral Palsy by Cairo University — 28 open to participants now, 34 under way, 1 of them phase 3. Cerebral Palsy · Cairo University.

Planned enrollment
68th of 94
30 · median 40
Started
2026
with 17 others
No phase
93 of 114
23 open now
Primary completion
2026-07
later than 21 of 33 live
Registered
103rd of 114
by date

Among the 114 studies in Cerebral Palsy by Cairo University, this one is the 68th largest by planned enrollment of the 94 interventional ones that give a count, is one of 18 that started in 2026, is one of 93 with no phase, reaches primary completion later than 21 of the 33 other live ones, and was the 103rd registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

28 of the 114 studies in Cerebral Palsy by Cairo University are open now, in 1 country. Recruiting first, the newest first:

22 more — sign in →

By country, each count listing its studies:

All 28 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 8 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Cerebral Palsy by Cairo University, or all of them as a file.
02

Study summary

  • To determine the effect of modified constraint-induced movement therapy on spatial and temporal gait parameters in children with hemiplegia.
  • To determine the effect of modified constraint-induced movement therapy on functional mobility in children with hemiplegia.
Read the detailed description

Children with spastic hemiplegic cerebral palsy experience longer gait cycles, slower walking speeds, and longer support phases compared to healthy children, with substantial joint angle differences noted during ground contact and stride buffering. Although most can achieve independent walking, they often exhibit poor motor coordination, resulting in short strides and high stride frequencies for speed maintenance. Modified constraint-induced movement therapy has been employed to enhance lower-extremity function, but its effectiveness on key ambulation aspects like gait speed and balance remains unclear. The reliance on the unaffected limb further impacts locomotive behavior, leading to stiff knee gait and reduced functional mobility. This study aims to explore the therapy's effects on locomotion in hemiplegic children.

03

Conditions studied

  • Spastic Hemiplegic Cerebral Palsy

Browse trials for

04

Who can participate

Ages eligible
6 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. The age of the selected children will range from 6 to 8 years old.
  2. Degree of spasticity will range from 1+ to 2 according to the modified Ashworth scale.
  3. The level of motor function of the children will be levels I-II according to the Gross Motor Function Classification System.
  4. Participants will present a score between 41 to 56 points on the pediatric balance scale.
  5. They will be able to follow instructions and understand commands.

Exclusion criteria

Exclusion Criteria:

  1. Bone and tendon lengthening surgeries within the last 6 months.
  2. Lung and heart diseases and disorders.
  3. Vision or hearing problems.
  4. Children with fixed deformities in the lower extremity.
  5. Children with epilepsy.
  6. Recent intramuscular Botulinum toxin injection.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Modified constraint induced movement therapy

    Fifteen children will receive a conventional physical therapy program for 1 hour and modified constraint-induced movement therapy for 30 minutes 3 times per week for 4 weeks.

    Other: Modified constraint-induced movement therapy · Other: Conventional physical therapy

  • Active comparator
    Conventional physical therapy

    Fifteen children will receive conventional physical therapy program only for 1 hour 3 times per week for 4 weeks.

    Other: Conventional physical therapy

Interventions

  • OtherModified constraint-induced movement therapy

    Three tasks will be designed to be performed for 10 min each while using the knee scooter as a method of constraint-induced movement therapy The 3 tasks will be as follows: 1. Walking with knee scooter forward on 8 meter walkway 2. Walking with knee scooter backward on 8 meter walkway 3. Standing with the knee scooter on balance board

  • OtherConventional physical therapy

    1. Repetitive motor training following shaping task * Step on stool. * Squat to stand. * Pressing the pedal stepper. * Walking on treadmill. * Bicycle. * Air walker. 2. Behavioral strategies: * Walking with picking toys from ground * Passing obstacles * Walking with a ball, moving it by the lower extremity

06

What researchers measure

Primary outcomes

  1. assessment of spatial gait parameters

    Kinovea is a free 2D motion analysis software that facilitates inexpensive, sensor-free video-based motion assessments suitable for clinical practice. Its reliability has been established for measuring cervical range of motion (ROM) in both sagittal and frontal planes, dominant wrist joint ROM, shoulder ROM, and ankle joint ROM during walking. Additionally, it effectively measures spatial gait parameters, including stride length, step length, and hip, knee, and ankle angles at initial contact and mid-swing stages of the gait cycle. Required tools for its use include a walking area, digital camera, adhesive skin marks, and a tripod.

    Time frame: At baseline and after Four weeks

Secondary outcomes

  1. assessment of Temporal gait parameters

    Kinovea is a free 2D motion analysis software that utilizes inexpensive, sensor-free video-based techniques for clinical motion analysis. Its reliability is essential for assessing important psychometric properties, especially in measuring various range of motion (ROM) for cervical, shoulder, and ankle joints, as well as capturing gait parameters like stance and swing phases. Required tools for its use include a walking area, digital camera, adhesive skin marks, and a tripod.

    Time frame: At baseline and after four weeks

  2. assessment of the functional mobility

    The Gross Motor Function Measure (GMFM-88) is a reliable and valid assessment tool for measuring gross motor function in children with cerebral palsy, specifically focusing on standing (segment D) and walking/running (segment E). It is widely used in clinical and research settings to track changes over time or assess the impact of interventions. Due to its lengthy administration time, it is best used for annual or biannual evaluations or research studies, and testers should be well-versed in its use prior to administration.

    Time frame: At baseline and after four weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jul 2026, 1 month after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 1 month is below that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2026
First posted
Jul 7, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Jul 30, 2026
CompletionEst.
Aug 30, 2026
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07686809
Lead sponsor
Cairo University
Responsible party
Mohamed Ali Elsayed Taha (Principal investigator, Cairo University) — Principal investigator
First posted
Jul 7, 2026
Start date
Jun 1, 2026
Primary completion
Jul 30, 2026 (estimated)
Completion
Aug 30, 2026 (estimated)
Last update
Jul 7, 2026

Study contacts

Mohamed Ali Taha
Contact
dr.mo7amed.ali224@gmail.com
01022599920

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion